KEY FEATURES
| Full Name | Apolipoprotein A5 |
|---|---|
| Synonym | Apo-A5; APOA-V; APOAV; RAP3; Regeneration-associated protein 3 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 1.25-80ng/mL |
| Sensitivity | 0.49ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human APOA5 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human APOA5. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human APOA5 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human APOA5, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human APOA5. You can calculate the concentration of Human APOA5 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human APOA5 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 4.23 | 7.09 | 29.82 | 4.37 | 7.43 | 29.42 |
| Standard deviation | 0.23 | 0.31 | 1.24 | 0.27 | 0.42 | 1.12 |
| CV(%) | 5.32 | 4.34 | 4.16 | 6.13 | 5.62 | 3.81 |
RECOVERY
The recovery of Human APOA5 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-105 | 99 |
| EDTA plasma (n=8) | 94-106 | 100 |
| Cell culture media (n=8) | 89-103 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human APOA5 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with APOA5 ELISA Kits
| APOE ELISA Kit | publications with APOA5 and APOE |
| APOC3 ELISA Kit | publications with APOA5 and APOC3 |
| APOA1 ELISA Kit | publications with APOA5 and APOA1 |
| APOB ELISA Kit | publications with APOA5 and APOB |
| APOC2 ELISA Kit | publications with APOA5 and APOC2 |
| APOA4 ELISA Kit | publications with APOA5 and APOA4 |
| APOA2 ELISA Kit | publications with APOA5 and APOA2 |
| PPARA ELISA Kit | publications with APOA5 and PPARA |
Pathways associated with APOA5 ELISA Kit
| Chylomicron-mediated Lipid Transport Pathway | Chylomicron-mediated Lipid Transport Pathway |
| Fatty Acid, Triacylglycerol, And Ketone Body Metabolism Pathway | Fatty Acid, Triacylglycerol, And Ketone Body Metabolism Pathway |
| Lipid Digestion, Mobilization, And Transport Pathway | Lipid Digestion, Mobilization, And Transport Pathway |
| Lipoprotein Metabolism Pathway | Lipoprotein Metabolism Pathway |
| Metabolism Pathway | Metabolism Pathway |
| Metabolism Of Lipids And Lipoproteins Pathway | Metabolism Of Lipids And Lipoproteins Pathway |
| PPAR Signaling Pathway | PPAR Signaling Pathway |
| PPARA Activates Gene Expression Pathway | PPARA Activates Gene Expression Pathway |
| Regulation Of Lipid Metabolism By Peroxisome Proliferator-activated Receptor Alpha (PPARalpha) Pathway | Regulation Of Lipid Metabolism By Peroxisome Proliferator-activated Receptor Alpha (PPARalpha) Pathway |
Diseases associated with APOA5 ELISA Kit
| Dyslipidemias | publications with APOA5 and Dyslipidemias |
| Hypertriglyceridemia | publications with APOA5 and Hypertriglyceridemia |
| Hyperlipidemias | publications with APOA5 and Hyperlipidemias |
| Cardiovascular Diseases | publications with APOA5 and Cardiovascular Diseases |
| Heart Diseases | publications with APOA5 and Heart Diseases |
| Atherosclerosis | publications with APOA5 and Atherosclerosis |
| Arteriosclerosis | publications with APOA5 and Arteriosclerosis |
| Coronary Artery Disease | publications with APOA5 and Coronary Artery Disease |
| Insulin Resistance | publications with APOA5 and Insulin Resistance |
| Diabetes Mellitus, Type 2 | publications with APOA5 and Diabetes Mellitus, Type 2 |
Organs/Tissues associated with APOA5 ELISA Kit
| Liver | publications with APOA5 and Liver |
| Lung | publications with APOA5 and Lung |
